Get Permission
Rev Diabet Stud, 2005, 2(4):187-189 DOI 10.1900/RDS.2005.2.187

Limitations in Immunotherapy with CD3 Antibodies: Comment on the Article by Drs. Chatenoud and Bach

Damien Bresson, Matthias von Herrath

La Jolla Institute for Allergy and Immunology, Department of Developmental Immunology 3, 10355 Science Center Drive, San Diego, California 92121, USA.
Address correspondence to: Matthias von Herrath, e-mail:



Fulltext: HTML , PDF (174KB)

This article has been cited by other articles:

Induction of chimerism permits low-dose islet grafts in the liver or pancreas to reverse refractory autoimmune diabetes

Zhang C, Wang M, Racine JJ, Liu H, Lin CL, Nair I, Lau J, Cao YA, Todorov I, Atkinson M, Zeng D

Diabetes 2010. 59(9):2228-2236

Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis

Czaja AJ, Manns MP

Gastroenterology 2010. 139(1):58-72

"Persistence of Diabetes" - Why Has Research into Type 1 Diabetes not Made Significant Advances?

Sia C, Weinem M

Rev Diabet Stud 2006. 3(4):156-160